Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: Results from a randomized double blind controlled clinical trial

Định dạng: PDF / Số trang: 10

Nhắn tin với admin nếu không tải được